ReviewCancers2026

Sarcopenia as a Marker of Immunometabolic Vulnerability in Pancreatic Ductal Adenocarcinoma.

Mukund Karthik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.